Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 10, 2003, Pages 6227-6232

  El Yacoubi, Malika ^a   Bouali, Saoussen ^b   Popa, Daniela ^b   Naudon, Laurent ^a   Leroux Nicollet, Isabelle ^a   Hamon, Michel ^b   Costentin, Jean ^a   Adrien, Joëlle ^b   Vaugeois, Jean Marie ^a  

^a CNRS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; FLUOXETINE; SEROTONIN 1A RECEPTOR; SUCROSE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN LEVEL; BREEDING; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; FEMALE; FORCED SWIMMING TEST; GENETIC MODEL; HIPPOCAMPUS; HYPOTHERMIA; MALE; MOUSE; NERVE CELL STIMULATION; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; REM SLEEP; SEROTONIN METABOLISM; SLEEP PATTERN; SLEEP WAKING CYCLE; STRESS;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADAPTATION, PSYCHOLOGICAL; ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORADIOGRAPHY; CARRIER PROTEINS; CIRCADIAN RHYTHM; CORTICOSTERONE; DEPRESSION; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; FEEDING BEHAVIOR; FEMALE; HYPOTHERMIA, INDUCED; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED STRAINS; MODELS, PSYCHOLOGICAL; NERVE TISSUE PROTEINS; RAPHE NUCLEI; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SLEEP; SUCROSE; WAKEFULNESS;

ANIMALIA;

EID: 0037947386     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.1034823100     Document Type: Article

References (39)

1. Henn, F. A. & McKinney, T. (1987) in Psychopharmacology: The Third Generation of Progress, ed. Meltzer, H. Y. (Raven, New York), pp. 687-695.
2. Kendler, K. S., Walter, E. E., Truett, K. T., Heath, A. C., Neale, M. C., Martin, N. G. & Eaves L. J. (1994) Am. J. Psychiatry 151, 1605-1614.
3. Sham, P. C., Sterne, A., Purcell, S., Cherny, S., Webster, M., Rijsdijk, F., Asherson, P., Ball, D., Craig, I., Eley, T., et al. (2000) Twin Res. 3, 316-322.
4. Willner, P. (1990) Pharmacol. Ther. 45, 425-455.
5. Overstreet, D. H. (2002) Behav. Genet. 32, 335-348.
6. Stéru, L., Chermat, R., Thierry, B. & Simon, P. (1985) Psychopharmacology 85, 367-370.
7. Cryan, J. F., Markou, A. & Lucki, I. (2002) Trends Pharmacol. Sci. 23, 238-245.
8. Vaugeois, J.-M., Odièvre, C., Loisel, L. & Costentin, J. (1996) Eur. J. Pharmacol. 316, R1-R2.
9. Stéru, L., Chermat, R., Thierry, B., Mico, J.-A., Lenègre, A., Stéru, M., Simon, P. & Porsolt, R. D. (1987) Prog. Neuropsychopharmacol. Biol. Psychiatry 11, 659-671.
10. El Yacoubi, M., Ledent, C., Ménard, J.-F., Parmentier, M., Costentin, J. & Vaugeois, J.-M. (2000) Br. J. Pharmacol. 129, 1465-1473.
11. Le Cudennec, C., Naudin, B., Do Rego, J. C. & Costentin, J. (2002) Life Sci. 72, 163-171.
12. Boutrel, B., Franc, B., Hen, R., Hamon, M. & Adrien J. (1999) J. Neurosci. 19, 3204-3212.
13. Li, Q., Wichems, C., Heils, A., Lesch, K. P. & Murphy, D. L. (2000) J. Neurosci. 20, 7888-7895.
14. Evrard, A., Laporte, A. M., Chastanet, M., Hen, R., Hamon, M. & Adrien, J. (1999) Eur. J. Neurosci. 11, 3823-3831.
15. D'Amato, R. J., Largent, B. L., Snowman, A. M. & Snyder, S. H. (1987) J. Pharmacol. Exp. Ther. 242, 364-371.
16. Naudon, L., Leroux-Nicollet, I., Raisman-Vozari, R., Botton, D. & Costentin, J. (1995) Synapse 21, 29-36.
17. Falconer D. S. & Mackay T. F. C. (1996) Introduction to Quantitative Genetics (Longman, Harlow, U.K.).
18. Porsolt, R. D., Le Pichon, M. & Jalfre, M. (1977) Nature 266, 730-732.
19. Trullas, R., Jackson, B. & Skolnick, P. (1989) Psychopharmacology 99, 287-288.
20. Willner, P. (1997) Psychopharmacology 134, 319-329.
21. Kupfer, D. J. (1975) Biol. Psychiatry 11, 159-174.
22. Arborelius, L., Owens, M. J., Plotsky, P. M. & Nemeroff, C. B. (1999) J. Endocrinol. 160, 1-12.
23. Hirschfeld, R. M. (2000) J. Clin. Psychiatry 61, Suppl. 6, 4-6.
24. Pineyro, G. & Blier, P. (1999) Pharmacol. Rev. 51, 533-591.
25. Mann, J. J. (1999) Neuropsychopharmacology 21, Suppl. 2, 99S-105S.
26. Goodwin, G. M., De Souza, R. J. & Green, A. R. (1985) Nature 317, 531-533.
27. Sprouse, J. S. & Aghajanian, G. K. (1987) Synapse 1, 3-9.
28. Overstreet, D. H., Daws, L. C., Schiller, G. D., Orbach, J. & Janowsky, D. S. (1998) Pharmacol. Biochem. Behav. 59, 777-785.
29. Eley, T. C. & Plomin, R. (1997) Curr. Opin. Neurobiol. 7, 279-284.
30. Henderson, N. D. (1989) Behav. Genet. 19, 473-502.
31. Porsolt, R. D. & Lenègre, A. (1992) in Experimental Approaches to Anxiety and Depression, eds. Elliott, J., Heal, D. J. & Marsden, C. A. (Wiley, London), pp. 73-85.
32. Turri, M. G., Datta, S. R., DeFries, J., Henderson, N. D. & Flint, J. (2001) Curr. Biol. 11, 725-734.
33. Yoshikawa, T., Watanabe, A., Ishitsuka, Y., Nakaya, A. & Nakatani, N. (2002) Genome Res. 12, 357-366.
34. Adrien, J., Dugovic, C. & Martin, P. (1991) Physiol. Behav. 49, 257-262.
35. Dugovic, C., Maccari, S., Weibel, L., Turek, F. W. & Van Reeth, O. (1999) J. Neurosci. 19, 8656-8664.
36. Drevets, W. C. & Raichle, M. E. (1992) Psychopharmacol. Bull. 28, 261-274.
37. Naudon, L., El Yacoubi, M., Vaugeois, J.-M., Leroux-Nicollet, I. & Costentin J. (2002) Brain Res. 936, 68-75.
38. Maudhuit, C., Prévot, E., Dangoumau, L., Martin, P., Hamon, M. & Adrien, J. (1997) Psychopharmacology 130, 269-275.
39. Stockmeier, C. A., Shapiro, L. A., Dilley, G. E., Kolli, T. N., Friedman, L. & Rajkowska, G. (1998) J. Neurosci. 18, 7394-7401.